The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Abstract Background Albumin is frequently prescribed in cirrhotic patients with acute decompensation. However, the true cost effectiveness of albumin use in cirrhotic patients is still under debate. Objective To evaluate the cost-effectiveness of albumin in the treatment of decompensated cirrhosis i...

Full description

Bibliographic Details
Main Authors: M. Chris Runken, Paolo Caraceni, Javier Fernandez, Alexander Zipprich, Rashad Carlton, Martin Bunke
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Health Economics Review
Subjects:
Albumin
Decompensated cirrhosis
Cost-effectiveness
Online Access:http://link.springer.com/article/10.1186/s13561-019-0237-7

Internet

http://link.springer.com/article/10.1186/s13561-019-0237-7

Similar Items